esmolol has been researched along with Heart Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ollila, A; Pettilä, V; Sund, R; Vikatmaa, L; Wilkman, E | 1 |
| Hou, B; Liu, J; Liu, Z; Shi, Q; Yang, S; Yang, W; Zhang, G | 1 |
| Lennmyr, F; Martijn, C; Semenas, E; Wiklund, L; Zoerner, F | 1 |
| Anderson, WG; Borgman, RJ; Erhardt, PW; Gorczynski, RJ; Kam, ST; Lee, RJ; O'Donnell, JP; Reynolds, RD; Zaroslinski, J | 1 |
| Mehlhorn, U; Warters, RD | 1 |
| Maree, SM | 1 |
| Friedman, B; Scott, J; Seneff, M; Smith, M | 1 |
| Bateman, TM; Conklin, C; Czer, LS; Gray, RJ; Matloff, JM | 1 |
| Gray, RJ | 1 |
2 review(s) available for esmolol and Heart Diseases
| Article | Year |
|---|---|
Efficacy and safety of intravenous esmolol for cardiac protection in non-cardiac surgery. A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Bradycardia; Female; Heart; Heart Diseases; Hemodynamics; Humans; Hypotension; Male; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Propanolamines; Protective Agents; Randomized Controlled Trials as Topic; Safety | 2019 |
Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker.
Topics: Adrenergic beta-Antagonists; Critical Care; Heart Diseases; Humans; Propanolamines | 1988 |
2 trial(s) available for esmolol and Heart Diseases
| Article | Year |
|---|---|
[Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
Topics: Adrenergic beta-Antagonists; Arterial Pressure; Cardiac Output; Central Venous Pressure; Heart Diseases; Hemodynamics; Humans; Propanolamines; Prospective Studies; Shock, Septic; Stroke Volume; Treatment Outcome | 2014 |
Use of esmolol in hypertension after cardiac surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Administration Schedule; Female; Heart Diseases; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Postoperative Complications; Propanolamines; Random Allocation | 1985 |
5 other study(ies) available for esmolol and Heart Diseases
| Article | Year |
|---|---|
Milrinone and esmolol decrease cardiac damage after resuscitation from prolonged cardiac arrest.
Topics: Acid-Base Equilibrium; Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Cardiotonic Agents; Fluid Therapy; Heart Arrest; Heart Diseases; Male; Milrinone; Myocardium; Propanolamines; Survival Analysis; Swine; Troponin I; Vasoconstrictor Agents; Vasopressins | 2015 |
Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patient.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Heart Diseases; In Vitro Techniques; Myocardial Infarction; Propanolamines; Time Factors | 1982 |
Effect of the ultrashort-acting beta-blocker esmolol on cardiac function recovery.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Dogs; Heart Diseases; Humans; Propanolamines; Ventricular Function, Left | 1999 |
Esmolol: a unique beta adrenergic antagonist.
Topics: Adrenergic beta-Antagonists; Autonomic Nervous System; Critical Care; Heart Diseases; Humans; Propanolamines | 1990 |
Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability.
Topics: Adrenergic beta-Antagonists; Adult; Charcoal; Heart Diseases; Hemoperfusion; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Propanolamines; Suicide, Attempted; Theophylline | 1990 |